نظام التحقق من المنتجات يعمل الآن
[email protected]  ·  Singapore
Sigma Testo-C testosterone cypionate 200mg vial and box
الحقن

Testo-C®

Testosterone Cypionate 200 mg/mL

Testo-C contains testosterone cypionate 200mg per mL — the long-acting testosterone ester most commonly prescribed for testosterone replacement therapy in the United States.

المادة الفعالة
Testosterone Cypionate
التركيز
200 mg/mL
الشكل
Oil-based solution for intramuscular injection (MCT oil USP carrier)
العبوة
10 mL multi-dose vial
الفئة
الحقن
هل لديك هذا المنتج؟تحقّق من رمز الأمان الخاص به خلال ثوانٍ.
تحقق من المنتج

للمعلومات فقط — لا تُباع المنتجات عبر هذا الموقع.

معلومات المنتج

What Is Testosterone Cypionate 200mg?

Testo-C by Sigma Pharmaceuticals contains testosterone cypionate 200mg per mL. The cypionate ester releases testosterone slowly and steadily, with a half-life of about eight days. Testosterone itself is essential for muscle, bone, red blood cell production and overall wellbeing in men.

Medical Use and History

Testosterone cypionate was introduced in the early 1950s and remains the most frequently prescribed injectable form of testosterone replacement therapy (TRT) in the United States. It is used to treat male hypogonadism caused by testicular or pituitary conditions. Its predictable pharmacokinetics and long history of clinical use have made it a trusted choice among physicians for decades.

Benefits of Testosterone Cypionate 200mg

  • Stable, long-lasting testosterone levels
  • Supports muscle mass, bone density, mood and libido
  • Less frequent administration than short-acting esters

Formulation: pharmaceutical-grade MCT oil (USP) carrier with benzyl alcohol and benzyl benzoate, free of ethyl oleate.

Each vial of testosterone cypionate 200mg from Sigma carries a single-use security code for authenticity verification.

Testosterone Cypionate is a Schedule III controlled substance in the United States. The information on this page is provided for reference only.

تقارير مختبرات مستقلة

لم تُنشر تقارير مختبر لهذا المنتج بعد. جميع التقارير →